AA
IMNM icon

ALPS Advisors’s Immunome IMNM Stock Holding History

ALPS Advisors’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.42M Buy
+114,440
New +$2.45M 0.01% 462
2025
Q4 		– Sell
-39,261
Closed -$460K – 1036
2025
Q3 		$460K Sell
39,261
-7,674
-16% -$76.3K ﹤0.01% 755
2025
Q2 		$436K Sell
46,935
-15,609
-25% -$128K ﹤0.01% 699
2025
Q1 		$421K Buy
62,544
+12,074
+24% +$116K ﹤0.01% 615
2024
Q4 		$536K Buy
+50,470
New +$610K ﹤0.01% 594

Other funds holding IMNM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

ALPS Advisors's IMNM Position: Q2 2026 in Review

ALPS Advisors opened a new position in Immunome (IMNM) in Q2 2026: 114,440 shares worth $2.42M. The stake represents 0.01% of the portfolio and ranks #462 among its holdings. This is a return to the name: ALPS Advisors previously reported a position in IMNM as recently as Q3 2025.

ALPS Advisors first reported a position in IMNM in Q4 2024 and has held it in 5 quarters since. 55 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • ALPS Advisors held 114,440 shares of Immunome worth $2.42M as of Q2 2026.
  • Immunome was a new ALPS Advisors position in Q2 2026.
  • Immunome made up 0.01% of ALPS Advisors's portfolio in Q2 2026, its #462 holding.
  • ALPS Advisors first reported a position in Immunome in Q4 2024 and has held it in 5 quarters since.
  • 55 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.